Identification of peptide epitopes of MAGE-1, -2, -3 that demonstrate HLA-A3-specific binding

Cancer Immunology Immunotherapy

Volumn 42, Issue 4, 1996, Pages 246-250

  McIntyre, Catherine A ^a   Rees, Robert C ^a   Platts, Kathryn E ^a   Cooke, Catherine J ^a   Smith, M Olivia ^a   Mulcahy, Kevin A ^a   Murray, Anna K ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

HLA; MAGE; peptide binding; T2 assay

Indexed keywords

EPITOPE; HLA A2 ANTIGEN; PEPTIDE; TUMOR ANTIGEN;

ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; PEPTIDE MAPPING; PRIORITY JOURNAL; TUMOR IMMUNITY;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A3 ANTIGEN; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PEPTIDES;

EID: 0029884095     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050277     Document Type: Article

References (22)

1. Boon T, Cerottini J-C, Van den Eynde B, Bruggen P van der, Van Pel A (1994) Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 12:337
2. Bruggen P van der, Szikora J-P, Boël P, Wildmann C, Somville M, Sensi M, Boon T (1994). Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw* 1601. Eur J Immunol 24:2134
3. Bruggen P van der, Bastin J, Gajewski T, Coulie PG, Boël P, De Smet C, Traversari C, Townsend A, Boon T (1994) A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur J Immunol 24:3038
4. Celis E, Fikes J, Wentworth P, Sidney J, Southwood S, Maewall A, Del Guercio M-F, Sette A, Livingston B (1994) Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A allelles. Mol Immunol 31:1423
5. Cerundolo V, Elliott T, Elvin J, Bastin J, Rammensee H-G, Townsend A (1991) The binding affinity and dissociation rates of peptides for class I major histocompatability complex molecules. Eur J Immunol 21:2069
6. Crannage KE, Rogers K, Jacob G, Stoddard CJ, Thomas WEG, Potter CW, Rees RC (1991) Factors influencing the establishment of tumour infiltrating lymphocyte cultures from human breast carcinoma and colon carcinoma tissue. Eur J Cancer 27:149
7. DiBrino M, Parker KC, Shiloach J, Knierman M, Lukszo J, Turner RV, Biddison WE, Coligan JE (1993) Endogenous peptides bound to HLA-A3 posess a specific combination of anchor residues that permit identification of potential antigenic peptides. Proc Natl Acad Sci USA 90:1508
8. DiBrino M, Tsuchida T, Turner RV, Parker KC, Coligan JE, Biddison WE (1993) HLA-A1 and HLA-A3 T cell epitopes derived from Influenza virus proteins predicted from peptide binding motifs. J Immunol 151:5930
9. Disis ML, Smith JS, Murphy AE, Chen W, Cheever MA (1994) In vitro generation of human cytolytic T-cells specific for peptides derived from the HER-2/neu protooncogene protein. Cancer Res 54:1071
10. Engelhard VH (1994) Structure of peptides associated with MHC class I molecules. Curr Opin Immunol 6:13
11. Gaugler B, Van den Eynde B, Bruggen P van der, Romero P, Gaforio JJ, De Plaen E, Lethé B, Brasseur F, Boon T (1994) Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 179:921
12. Ghosh AK, Moore M (1992) Lymphocytes infiltrating cervical carinoma: Phenotypic and functional analysis. Eur J Cancer 11:1910
13. Houbiers JGA, Nijman HW, Burg SH van der, Drijfhout JW, Kenemans P, Velde CJH van de, Brand A, Momburg F, Kast WM, Melief CJM (1993) In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53. Eur J Immunol 23:2072
14. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, Miki T, Rosenberg SA (1994) Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 91:3515
15. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Sakaguchi K, Appella E, Yannelli JR, Adema GJ, Miki T, Rosenberg SA (1994) Identification of a melanoma anigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 91:6458
16. Kubo RT, Sette A, Grey HM, Appella E, Sakaguchi K, Zhu N-Z, Arnott D, Sherman N, Shabanowitz J, Michel H, Bodnar WM, Davis TA, Hunt DF (1994) Definition of specific peptide motifs for four major HLA-A alleles. J Immunol 152:3913
17. Nijman HW, Van der Burg SH, Vierboom MPM, Houbiers JGA, Kast WM, Melief CJM (1994) p53, a potential target for tumor-directed T cells. Immunol Lett 40:171
18. Ruppert J, Sidney J, Celis E, Kubo RT, Grey HM, Sette A (1993) Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929
19. Stuber G, Leder GH, Storkus WJ, Lotze MT, Modrow S, Székely L, Wolf H, Klein E, Kärre K, Klein G (1994) Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay. Eur J Immunol 24:765
20. + T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc Natl Acad Sci USA 91:9461
21. Traversari C, Bruggen P van der, Luescher IF, Lurquin C, Chomez P, Van Pel A, De Plaen E, Amar-Costesec A, Boon T (1992) A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 176:1453
22. Wölfel T, Van Pel A, Brichard V, Schneider J, Seliger B, Büschenfelde K-HM zum, Boon T (1994) Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur J Immunol 24:759